Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Anticoagulation in Reducing the Incidence of Splenic/Portal Vein Thrombosis Post-Laparoscopic Splenectomy Protocol Number: 5698

NCT00769873 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT00769873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Anticoagulation in Reducing the Incidence of Splenic/Portal Vein Thrombosis Post-Laparoscopic Splenectomy Protocol Number: 5698
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2006
Completion date
May 31, 2009
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

portal vein thrombosis, splenic vein thrombosis